Osteomyelitis is a type of bone infection that can rise from the bacteria circulating in the bloodstream. It is mainly caused by staphylococcus aureus but another organism is linked to the age of the patient and predisposing conditions. The patient suffering from this disease often experienced pain, fever, and chills.
The global osteomyelitis market is expected to witness significant growth during the forecast period. As per the records of NCBI in 2016, the total annual incidence rate of osteomyelitis was 13 per 100,000 (acute osteomyelitis eight and subacute osteomyelitis five per 100,000) worldwide. In addition to this, the surgery segment is projected to grow at a CAGR of 6.7% in the previously mentioned forecast period. The enormous number of disposable and reusable electrosurgical tools accounts for this segment's considerable proportion.
Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-osteomyelitis-market
Data Bridge Market Research analyses a growth rate in the global osteomyelitis market in the forecast period 2022-2029. The expected CAGR of global osteomyelitis market is tend to be around 7.50% in the mentioned forecast period. The market was valued at USD 0.89 billion in 2021, and it would grow upto USD 1.59 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Opportunities
Increasing Demand for Retail Pharmacies
The rise in the number of drugs for osteomyelitis delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Growing Cases of Diabetes
According to the World Journal of Diabetes in 2017, diabetic patients are at a greater risk for osteomyelitis. In the recent, years, the occurrence of the osteomyelitis has increased. According to the American Diabetes Association in 2015, approximately 30.3 million Americans results for 9.4% of the population within the region had diabetes. The occurrence of diabetes is projected to boost the market.
Osteomyelitis Market Regional Analysis/Insights
Asia-Pacific has been witnessing a positive growth for global osteomyelitis market throughout the forecasted period to the rise in cases of osteomyelitis and favourable government policies as well as advanced healthcare facilities. North America dominates the market due to the rise in cases of osteomyelitis, favourable government policies, and advanced healthcare facilities.
Some of the major key players operating in the market are Novartis AG (Switzerland), Fresenius Kabi AG (Germany), Akorn Incorporated (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V (U.S.), Johnsons & Johnsons Services Inc (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Lilly (U.S.), Merck & Co., Inc. (U.S.), Aurobindo Pharma (India), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Siemens Healthcare GmbH (U.S.), Shimadzu Corporation (Japan), GeneDx, LLC (U.S.) among others
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475